PSMB9 and non-small cell lung carcinoma: The β1i subunit, encoded by PSMB9, was found to be reduced in breast cancer, renal cell carcinoma, APL, and NSCLC while elevated in melanoma and ovarian cancer [150,156,157,164,166,167,168,169].